RT

Rick Tsai

CEO at LUCA Science Inc.

Greater Tokyo Area

Investor
VC

Invests in

Stages:

Series A
Seed

Locations:

Tokyo

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Medicine
Pharmaceutical Industry
Clinical Trials
Clinical Development
Clinical Research
Oncology
Healthcare
Drug Development
Lifesciences
Biotechnology
Medical Devices
Regulatory Affairs
Medical Affairs
Medical Education
Orthopedic
Osteoporosis
Translational Medicine
Plastic Surgery
General Surgery
Dentistry

Education

Lists including Rick

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

LS
LUCA Science Inc.

2020

  • Chief Executive Officer

    2020

AC
Axil Capital Partners, Axil Capital Advisors K.K.

2020

  • Venture Partner

    2020

P
PhRMA

2016 - 2020

  • Vice Chairman Medical Affairs Committee Japan

    2016 - 2020

M
Merck

2012 - 2020

  • Head of Medical Affairs / Executive Officer MSD KK / Associate Vice President

    2012 - 2020

A
Allergan

2011 - 2012

  • Medical Director Japan, Taiwan & Hong Kong

    2011 - 2012

M
Merck

2006 - 2011

  • Senior Director, Head of Regulatory Affiars, Japan Development

    2006 - 2011

West Coast Oral & Maxillofacial Surgery Center Dr. Peter K Moy

2005 - 2006

  • Associate Surgeon

    2005 - 2006

NY
New York-Presbyterian Hospital

1999 - 2005

  • Resident

    1999 - 2005

    Oral and Maxillofacial Surgery